The document discusses strategies and rationale for decreasing secondary brain injury following traumatic brain injury (TBI). It describes that TBI consists of primary and secondary brain injury, with primary injury occurring immediately from mechanical forces and secondary injury developing over time from cellular and biochemical cascades. The document outlines various mechanisms of secondary injury including excitotoxicity, inflammation, edema, and ischemia. It then provides recommendations for treating and monitoring TBI to decrease secondary injury, such as decompressive craniectomy, ICP/CPP monitoring, ventilation strategies, hypothermia, hyperosmolar therapy, and seizure prophylaxis.
70% of RTA patients have head injury(HI).
One of the most important public health problems of today.
70% of deaths in RTA are due to HI.
At Risk population
Males 15-24
Infants
Young Children
Elderly
70% of RTA patients have head injury(HI).
One of the most important public health problems of today.
70% of deaths in RTA are due to HI.
At Risk population
Males 15-24
Infants
Young Children
Elderly
The most common cause of death in young is non other than Head injury. The modern advances not only gave human mankind a luxury but with high velocity injury there is high burden of head injury too. This slide is updated with BTF 2016 guideline
The most common cause of death in young is non other than Head injury. The modern advances not only gave human mankind a luxury but with high velocity injury there is high burden of head injury too. This slide is updated with BTF 2016 guideline
HEAD INJURY- AN OVERVIEW
Dear viewers,
Greetings from “Surgical Educator”
Today I have uploaded a video on Head injury- an important topic in trauma because 50% of trauma deaths are due to head injuries. I haven’t talked elaborately but have included the essential minimum an undergraduate medical student should know. I have talked about pathophysiology, clinical approach, symptoms, signs, investigations, different individual types of head injuries and management of all the varieties of head injuries. My aim is after watching this video all of you should be able to arrive at a correct working diagnosis of the type of head injury and should also be able to institute immediate lifesaving treatment to the patients if there is a need. You can watch the video in the following links:
Surgicaleducator.blogspot.com
Youtube.com/c/surgicaleducator
Thank you for watching the video.
journal club and critical appraisal checklist
intensive recruitment versus moderate recruitment strategy in postop cardiac surgery patients to avaoid postop pulmonary complications
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Evaluation of antidepressant activity of clitoris ternatea in animals
TRAUMATIC BRAIN INJURY
1. TRAUMATIC BRAIN INJURY
STRATEGIES AND RATIONALE TO DECREASE
SECONDARY BRAIN INJURY
PRESENTER - DR YOGESH RATHOD
MODERATOR – DR SHALINI NAIR
2. TRAUMATIC BRAIN INJURY
Consists of two types of injuries:-
Primary Brain injury is the damage sustained as a direct result of the impact on the skull and
intracranial contents.
Secondary brain injury refers to the changes that evolve over a period of time (from hours to days)
after the primary brain injury.
It includes an entire cascade of cellular, chemical, tissue, or blood vessel changes in the brain that
contribute to further destruction of brain tissue.
3. PATHOPHYSIOLOGY
Primary brain Injury — heterogenous.
Common mechanisms
direct impact
rapid acceleration/deceleration
penetrating injury
blast waves.
External mechanical force damage results in
focal contusions and hematomas
shearing of white matter tracts (diffuse axonal injury)
cerebral edema and swelling.
4. Secondary brain Injury
These mechanisms include:
Neurotransmitter-mediated excitotoxicity (e.g. glutamate), free-radical injury to cell membranes
Electrolyte imbalances
Mitochondrial dysfunction
Inflammatory responses
Apoptosis
Secondary ischemia from vasospasm, focal microvascular occlusion, vascular injury
Current clinical approaches to the management of TBI center around primary and secondary brain injury
concepts.
7. LIBERATION OF
CHEMICALS
(EAAs, PAF & Free
Radicals of O2)
DISRUPTION OF BBB
EDEMA
NEURAL DEATH
CONTINUATION OF
VICIOUS CYCLE
Neurotoxic cascades
ISCHAEMIA
AND
REPERFUSION
INJURY
8. Calcium channel disturbance
Local tissue damage EAAs NMDA glutamate receptors of calcium channels in the surroundings
cells massive influx of Ca++ ions metabolic failure of the cells and cellular edema.
Oxygen free radical production
Cellular metabolic failure free radicals of oxygen + PAF free radical generation and the
destruction of super oxide dismutase damaged cells and blood vessels Ischemia and vascular
damage arachidonic acid cascade prostaglandin, prostacyclin leukotrienes release with free
radical generation further vascular damage increase in vascular permeability and vasogenic
oedema further brain swelling & raised ICP, a decrease in CPP and more global ischaemia.
9. Hematoma formation
Exrtadural hematomalocal ischemia, a shift of midline structures and possible fatal brainstem
damage
Subdural and subarachnoid hemotoma local compression and swelling of the brain substance
and an increase in ICP
Blood in the subarachnoid space can cause vasospasm and further aggravate cerebral ischemia.
10. Respiratory failure
LOC accompanied by a period of central apnea and can lead to severe hypoxia.
Aspiration of vomit can cause further injury to lungs impairing ventilation.
Any hypoxia will aggravate cerebral ischemia and increases cerebral blood flow and cerebral blood
volume, thus increasing ICP.
Thus any degree of respiratory failure is particularly hazardous for the patient with head injury.
Blood Loss
CPP = MAP – ICP
Raised ICP + fall in MAP cerebral ischaemia.
Hypotension from blood loss is not uncommon in multiple injuries and should be strenuously avoided
and corrected. Blood loss can lead to anemia and make cerebral ischemia more likely
11. Infection and Seizure
A major source of concern .
Any patient with a CSF leak or air in the intracranial cavity and open fracture of the skull
should be given an appropriate prophylactic antibiotic regimen
Epileptic seizures
Early epilepsy is most likely to be associated with intracranial haematoma and depressed skull
fracture. If the seizures are not controlled, they can cause cerebral hypoxia
13. TREATMENT RECOMMENDATIONS
Decompressive craniectomy
Bifrontal DC is not recommended to improve outcomes. But reduces ICP and minimizes days in the
ICU.
A large fronto-temporo-parietal DC (not less than 12 x 15 cm or 15 cm diameter) is recommended
over a small FTP DC for reduced mortality and improved neurologic outcomes.
Ventilation therapies
Prolonged prophylactic hyperventilation with PaCO2 of 25 mm Hg is not recommended.
Hyperventilation is recommended as a temporizing measure for the reduction of elevated ICP.
Hyperventilation avoided during the first 24 h when CBF often is reduced critically.
If hyperventilation is used, SjO2 or BtpO2 measurements are recommended to monitor oxygen
delivery.
14. Prophylactic hypothermia
Early (within 2.5 h), short-term (48 h post-injury), prophylactic hypothermia is not recommended to
improve outcomes in patients with diffuse injury.
Hyperosmolar therapy
Mannitol is effective for control of raised ICP at doses of 0.25 to 1 g/kg body weight. Arterial hypotension
(systolic blood pressure ,90 mm Hg) should be avoided.
Restrict mannitol use prior to ICP monitoring to patients with signs of transtentorial herniation or
progressive neurologic deterioration not attributable to extracranial causes.
Cerebrospinal fluid drainage
An EVD system zeroed at the midbrain with continuous drainage of CSF may be considered to lower ICP
burden more effectively than intermittent use.
Use of CSF drainage to lower ICP in patients with an initial GCS of 6 or lower during the first 12 h after
injury may be considered.
15. Anesthetics, analgesics, and sedatives
Barbiturates for burst suppression in EEG as prophylaxis against development of intracranial HTN not
recommended.
High-dose barbiturate recommended to control elevated refractory ICP. Hemodynamic stability essential.
Propofol is recommended for the control of ICP, but not recommended for improvement in mortality or 6-
month outcomes. Caution is required as high-dose propofol can produce significant morbidity.
Steroids
Not recommended for improving outcome or reducing ICP. Rather high dose methylpred was a/w increased
mortality and is contraindicated.
Nutrition
Feeding patients to attain basal caloric replacement at least by the 5th day and at most by the 7th day
recommended to decrease mortality.
16. Infection prophylaxis
Early trach recommended to reduce mechanical ventilation days if overall benefit outweighs the complications. No
evidence that early trach reduces mortality or the rate of nosocomial pneumonia.
PI oral care is not recommended to reduce VAP and may cause an increased risk of ARDS.
Antimicrobial-impregnated catheters may be considered during EVD to prevent infections.
DVT Prophylaxis
LMWH or low-dose unfractionated heparin may be used in combination with mechanical prophylaxis. But an
increased risk for expansion of ICH.
Compression stockings + pharmacologic prophylaxis may be beneficial.
Insufficient evidence to support recommendations regarding the preferred agent, dose, or timing of pharmacologic
prophylaxis for DVT.
Seizure prophylaxis
Prophylactic use of phenytoin or valproate is not recommended for preventing late PTS.
Phenytoin is recommended to decrease the incidence of early PTS (within 7 d of injury), when the overall benefit
outweighs the complications. However, early PTS have not been associated with worse outcomes.
Insufficient evidence to recommend levetiracetam over phenytoin regarding efficacy in preventing early PTS and
toxicity.
17. MISCELLANEOUS
Antagonists or blockers of the NMDA glutamate receptor (dizocilpine) have been successful in
preventing brain injury in animals.
Nimodipine have also been shown to have some brain protective effects.
Ketamine is an NMDA receptor antagonist that has been shown to improve neurological
outcome in a rat brain injury model, but no practical value in a clinical settings.
Nitric oxide production of free radicals (by blocking nitric oxide synthase, outcome is
improved)
Antagonists to PAF and leucocytes antibody treatment may also limit secondary brain injury.
18. Intracranial pressure monitoring
Management of severe TBI patients using information from ICP monitoring is recommended to reduce in hospital
and 2-week post-injury mortality.
Monitored in all salvageable patients with a TBI (GCS 3-8 after resuscitation) and an abnormal CT scans.
Indicated in patients with severe TBI with a normal CT scan if >2 OR 2 of the following features are noted at
admission:
age >40 years,
unilateral or bilateral motor posturing, or
SBP <90 mm Hg.
Advanced cerebral monitoring
Jugular bulb monitoring of AVDO2 may be considered important parameter to reduce mortality and improve
outcomes at 3 and 6 mo post-injury.
Cerebral perfusion pressure monitoring
Management of severe TBI patients using guidelines-based recommendations for CPP monitoring is
recommended to decrease 2-wk mortality.
MONITORING RECOMMENDATIONS
19. Blood pressure thresholds - Maintaining SBP at >100 mm Hg OR equal for patients 50 to 69 years old
or at >110 mm Hg or equal or above for patients 15 to 49 or >70 years old may be considered to
decrease mortality and improve outcomes.
Intracranial pressure thresholds - Treating ICP >22 mm Hg is recommended because values above this
level are associated with increased mortality. A combination of ICP values and clinical and brain CT
findings may be used to make management decisions.
Cerebral perfusion pressure thresholds - The recommended target CPP value for survival and
favorable outcomes is between 60 and 70 mm Hg. Whether 60 or 70 mm Hg is the minimum optimal
CPP threshold is unclear and may depend upon the autoregulatory status of the patient. Avoiding
aggressive attempts to maintain CPP >70 mm Hg with fluids and pressors may be considered because
of the risk of adult respiratory failure.
Advanced cerebral monitoring thresholds - Jugular venous saturation of <50% may be a threshold to
avoid in order to reduce mortality and improve outcomes.
THRESHOLD RECOMMENDATIONS
20. Diffuse axonal injury
CT scan of the brain
showing diffuse axonal
injury (DAI). Note the deep
shearing-type injury in or
near the white matter of
the left internal capsule
(arrow).
21. Frontal cerebral contusion
CT scan of the brain
depicting cerebral
contusions. The basal
frontal areas (as shown)
are particularly
susceptible.
23. Traumatic subdural hematoma
CT scan showing a left acute
subdural hematoma (SDH, arrow).
Subdural hematomas are typically
crescent-shape. In this case the
SDH is causing significant mass
effect and shift of midline
structures to the right.
25. Intracerebral Hemorrhage
CT obtained less than six hours
from symptom onset in a patient
with spontaneous acute
intracerebral hemorrhage. The CT
scan shows a hyperdense
hemorrhage predominantly in the
left frontal lobe.
26. SUMMARY
TBI encompasses a broad range of pathologic injuries of varying clinical severity.
TBI is universally categorized as mild, moderate, and severe based on GCS.
The pathophysiology of TBI includes primary and secondary brain injury.
The pathoanatomical sequelae of primary TBI include intra- and extra parenchymal hemorrhages and
DAI.
Secondary TBI results from a cascade of molecular injury mechanisms and can be exacerbated by
modifiable systemic events such as hypotension, hypoxia, fever, and seizures
Surgical treatment of primary brain injury lesions is central to the initial management.
Likewise, the identification, prevention, and treatment of secondary brain injury is the principle
focus of neurointensive care management.
27. NO QUESTIONS! JUST SELF HELP!
INDIAN JOURNAL OF NEUROTRAUMA
BRAIN TRAUMA FOUNDATION GUIDELINES 2016
UPTODATE
NEUROTRAUMA TEXTBOOKS
Editor's Notes
— A cascade of molecular injury mechanisms that are initiated at the time of initial trauma and continue for hours or days.
These lead in turn to neuronal cell death and to cerebral edema with increased ICP that can further exacerbate the brain injury.
Mimics like ischemic cascade in acute stroke.
These various pathways of cellular injury have been the focus of extensive preclinical work into the development of neuroprotective treatments to prevent secondary brain injury in TBI. No clinical trials of these strategies have demonstrated clear benefit in patients.
However, a critical aspect of ameliorating secondary brain injury after TBI is the avoidance of secondary brain insults, which would otherwise be well-tolerated but can exacerbate neuronal injury in cells made vulnerable by the initial TBI. Examples include hypotension and hypoxia (which decrease substrate delivery of oxygen and glucose to injured brain), fever and seizures (which may further increase metabolic demand), and hyperglycemia (which may exacerbate ongoing injury mechanisms).
&lt;number&gt;
&lt;number&gt;
as measured by the GOS-E score at 6month post-injury in severe TBI patients with diffuse injury (without mass lesions), and with ICP elevation to values 20mmHg for &gt;15 min within 1 hr period that are refractory to first-tier therapies.
&lt;number&gt;
Shearing mechanisms lead to diffuse axonal injury (DAI), which is visualized pathologically and on neuroimaging studies as multiple small lesions seen within white matter tracts .
Severe DAI presents with profound coma without elevated ICP, and often have poor outcome.
This typically involves the gray-white junction in the hemispheres, with more severe injuries affecting the corpus callosum and/or midbrain.
MRI (in particular diffusion tensor imaging) is more sensitive than CT for detecting DAI, and the sensitivity of the test declines if delayed from the time of injury.
&lt;number&gt;
Focal cerebral contusions are the most frequently encountered lesions.
Contusions are commonly seen in the basal frontal and temporal areas, which are susceptible due to direct impact on basal skull surfaces in the setting of acceleration/deceleration injuries.
Coalescence of cerebral contusions or a more severe head injury disrupting intraparenchymal blood vessels may result in an intraparenchymal hematoma.
&lt;number&gt;
Extra-axial (defined as outside the substance of the brain) hematomas are generally encountered when forces are distributed to the cranial vault and the most superficial cerebral layers. These include epidural, subdural, and subarachnoid hemorrhage.
In adults, epidural hematomas (EDH) are typically associated with torn dural vessels such as the middle meningeal artery, and are almost always associated with a skull fracture. EDHs are lenticular-shaped and tend not to be associated with underlying brain damage. For this reason, patients who are found to have EDHs only on CT scan may have a better prognosis than individuals with other traumatic hemorrhage types.
&lt;number&gt;
•Subdural hematomas (SDH) result from damage to bridging veins, which drain the cerebral cortical surfaces to dural venous sinuses, or from the blossoming of superficial cortical contusions. They tend to be crescent-shaped and are often associated with underlying cerebral injury.
&lt;number&gt;
•Subarachnoid hemorrhage (SAH) can occur with disruption of small pial vessels and commonly occurs in the sylvian fissures and interpeduncular cisterns. Intraventricular hemorrhage or superficial intracerebral hemorrhage may also extend into the subarachnoid space.
&lt;number&gt;
•Intraventricular hemorrhage is believed to result from tearing of subependymal veins, or by extension from adjacent intraparenchymal or subarachnoid hemorrhage.
&lt;number&gt;